Celgene profit beats as psoriasis drug sales surge

Celgene Corp, which is being bought by Bristol-Myers Squibb Co, reported a better-than-expected fourth-quarter profit on Thursday, driven mainly by higher sales of psoriasis drug Otezla.


from Reuters: Health News https://reut.rs/2MGE8Yw

Comments

Popular posts from this blog

PSL 2018: DWP Group becomes title sponsor of Lahore Qalandars

Tonga bans rugby, boxing for girls 'to preserve dignity'